The founding members of EUFEMED
Healixia formed in 2020 following the merging of a group of Belgian professional bodies (BAPU, ACRP.be, BeAPP and BRAS) who shared interests in the life cycle of medicines, medical devices and diagnostics. Members are active in research and development (including pre-clinical, early clinical and later phases), medical affairs, safety, regulatory affairs and market access across industry, academia and regulatory bodies. Healixia’s mission is to advance the professionalism of its members and to work with relevant stakeholders to build a strong community of professionals in Belgium.
Through its activities Healixia provides development, education, training and networking opportunities for all members.
Association Française de Pharmacologie Translationnelle
Founded in 1993, AFPT (formerly Club Phase I) is a French non-profit association whose members are physicians and scientists from stakeholder organisations (the pharmaceutical industry, contract research organisations and academia) involved in human pharmacology and translational medicine.
The aim of AFPT is to support and promote clinical research into healthcare products in France. Our mission is to facilitate methodological, regulatory and ethical exchanges between all parties engaged in the advancement of new therapies with emphasis on clinical pharmacology and early phase development. AFPT also commits to promote activities to support furthering the process, conduct and understanding of clinical science.
The Association for Applied Human Pharmacology, founded in 1991, is a scientific medical not for profit organisation which members work in the field of explorative drug development and human pharmacology.
The organisation is particular open for professionals who work in the field of translational medicine i.e. bringing new medicinal products from the bench into clinical research.
The Association for Human Pharmacology in the Pharmaceutical Industry (AHPPI) is the oldest not-for-profit professional association involved in early phase drug development in the world. Founded in 1988, it provides a forum for continuing education in clinical pharmacology and in the regulatory aspects of early development of new medicines.
The membership of AHPPI includes physicians, nurses, clinical scientists and project managers who work for organisations, such as pharmaceutical companies and contract research organisations involved in developing new therapies and conducting clinical trials.